0001237899-12-000063.txt : 20120727 0001237899-12-000063.hdr.sgml : 20120727 20120727111048 ACCESSION NUMBER: 0001237899-12-000063 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120725 FILED AS OF DATE: 20120727 DATE AS OF CHANGE: 20120727 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Powchik Peter CENTRAL INDEX KEY: 0001377247 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 12989356 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2012-07-25 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001377247 Powchik Peter 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 SVP Clinical Development & Reg Common Stock 2012-07-25 4 M 0 15000.0 16.8 A 30144.0 D Common Stock 2012-07-25 4 F 0 1987.0 126.76 D 28157.0 D Common Stock 2012-07-25 4 F 0 5994.0 126.76 D 22163.0 D Common Stock 2012-07-26 4 S 0 4519.0 130.4 D 17644.0 D Common Stock 2012-07-26 4 S 0 2500.0 131.07 D 15144.0 D Common Stock 1532.0 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 16.8 2012-07-25 4 M 0 15000.0 D 2011-12-17 2018-12-17 Common Stock 15000.0 15000.0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 4,519 shares of Company stock on July 26, 2012 at prices ranging from $130.21 to $130.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 26, 2012 at each separate price. Represents volume-weighted average price of sales of 2,500 shares of Company stock on July 26, 2012 at prices ranging from $131.05 to $131.08. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 26, 2012 at each separate price. On December 17, 2008, the reporting person was granted an option to purchase 30,000 shares of Common Stock. The option was eligible to vest, partially or in full, on December 31, 2011, based on the extent to which the company satisfied certain performance criteria. The performance criteria were met and the option vested as to all shares. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case. /s/**Peter Powchik 2012-07-27